Goldman Sachs is raising estimates on shares of Sara Lee SLE, and the price target goes to $22 from $19, but it has a Neutral rating on shares.
In a note to clients, Goldman Sachs writes, "We are raising our estimates and price target on SLE ahead of a series of potential catalysts. We believe that restructuring and headcount reduction initiatives have been advanced in SLE's North American operations. When combined with the recent 14% percent drop in coffee costs, we raise our base case FY12 EPS estimate to $1.17, $0.10 ahead of our prior estimate and 13% above consensus. Our FY13/FY14 estimates rise to $1.35/$1.45, from $1.23/$1.33, on a higher base."
Shares of SLE gained 17 cents yesterday to close at $19.43, a gain of 0.88%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsConsumer StaplesGoldman SachsPackaged Foods & Meats
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in